Hiroshi Katoh Selected Research

Carcinoembryonic Antigen

9/2011	Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.
5/2008	Diminishing impact of preoperative carcinoembryonic antigen (CEA) in prognosis of Dukes' C colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Katoh Research Topics

Disease

30	Neoplasms (Cancer) 01/2023 - 06/2003
9	Infections 10/2022 - 07/2002
9	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 05/2008
7	Breast Neoplasms (Breast Cancer) 05/2019 - 01/2014
4	Adenoma (Adenomas) 01/2021 - 05/2003
4	Stomach Neoplasms (Stomach Cancer) 09/2017 - 10/2009
4	Pituitary Neoplasms (Pituitary Adenoma) 06/2003 - 01/2002
3	Pancreatic Neoplasms (Pancreatic Cancer) 09/2019 - 11/2002
2	Ischemic Stroke 11/2022 - 01/2013
2	Stroke (Strokes) 11/2022 - 01/2013
2	Virus Diseases (Viral Diseases) 01/2021 - 12/2008
2	Adenocarcinoma 09/2019 - 02/2019
2	Rectal Neoplasms (Rectal Cancer) 05/2019 - 09/2011
2	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2008
2	Lymphatic Metastasis 11/2018 - 06/2008
2	Carcinoma (Carcinomatosis) 01/2018 - 12/2014
2	Colonic Neoplasms (Colon Cancer) 09/2011 - 08/2009
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2004 - 06/2004
1	Phlebitis 02/2024
1	Thyroiditis 02/2024
1	Fibrosis (Cirrhosis) 02/2024
1	Graves Disease (Basedow Disease) 02/2024
1	COVID-19 01/2023
1	Thrombosis (Thrombus) 11/2022
1	Anaplastic Thyroid Carcinoma 01/2022
1	Mumps 01/2022
1	Hyperparathyroidism 01/2021
1	Primary Hyperparathyroidism 01/2021
1	Severe Acute Respiratory Syndrome 09/2020
1	Hereditary Breast and Ovarian Cancer Syndrome 09/2020
1	Ductal Carcinoma 09/2020
1	Neutropenia 12/2019
1	Esophageal Squamous Cell Carcinoma 12/2019
1	Thyroid Neoplasms (Thyroid Cancer) 12/2019
1	Diarrhea 12/2019
1	Oncogene Addiction 01/2019
1	Flavivirus Infections 01/2018
1	Residual Neoplasm 09/2017
1	Gallbladder Diseases (Gall Bladder Disease) 01/2017
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2017
1	Primitive Neuroectodermal Tumors (PNET) 10/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2016
1	Nausea 03/2016
1	Vomiting 03/2016
1	Triple Negative Breast Neoplasms 01/2016

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 09/2019 - 04/2006
8	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2006
8	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2011
6	Cysteine Dioxygenase (Dioxygenase, Cysteine)IBA 09/2019 - 01/2016
3	Genetic Markers (Genetic Marker)IBA 12/2019 - 09/2017
3	ProstaglandinsIBA 01/2012 - 03/2010
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 06/2003 - 01/2002
2	Homeodomain Proteins (Proteins, Homeobox)IBA 05/2019 - 11/2013
2	AntigensIBA 02/2019 - 01/2005
2	Messenger RNA (mRNA)IBA 09/2017 - 07/2012
2	PlatinumIBA 01/2016 - 06/2002
2	Dinoprostone (PGE2)FDA Link 01/2012 - 03/2010
2	Prostaglandins EIBA 01/2012 - 07/2010
2	Carcinoembryonic AntigenIBA 09/2011 - 05/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2010 - 05/2003
1	Thyroid HormonesIBA 02/2024
1	Immunoglobulins (Immunoglobulin)IBA 02/2024
1	Immunoglobulin G (IgG)IBA 02/2024
1	Long-Acting Thyroid Stimulator (LATS)IBA 02/2024
1	Viral RNAIBA 10/2022
1	lenvatinibIBA 01/2022
1	Mumps Vaccine (Vaccine, Mumps)IBA 01/2022
1	tetraethylpyrazine (TEP)IBA 01/2021
1	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 09/2020
1	Phenobarbital (Luminal)FDA Link 09/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2020
1	palbociclibIBA 12/2019
1	YM753 compoundIBA 12/2019
1	abemaciclibIBA 12/2019
1	CarbohydratesIBA 02/2019
1	Cytosine NucleotidesIBA 12/2018
1	Hormones (Hormone)IBA 11/2018
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 10/2016
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 03/2016
1	AnthracyclinesIBA 03/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2016
1	EmeticsIBA 03/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2016
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 03/2016
1	AntiemeticsIBA 03/2016
1	Palonosetron (Aloxi)FDA Link 03/2016
1	Aprepitant (Emend)FDA Link 03/2016
1	InterferonsIBA 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2016

Therapy/Procedure

10	Therapeutics 01/2022 - 07/2002
4	Drug Therapy (Chemotherapy) 03/2016 - 08/2009
2	Neoadjuvant Therapy 12/2019 - 01/2016
1	Treatment Delay 01/2023
1	Thrombectomy 11/2022
1	Stents 11/2022
1	Operative Surgical Procedures 01/2021
1	Parathyroidectomy 01/2021
1	Mastectomy (Mammectomy) 09/2020
1	Adjuvant Chemotherapy 01/2017